期刊文献+

Cervi-M宫颈癌甲基化基因检测其诊断应用价值分析 被引量:2

Analysis of Diagnostic Application Value of Gene Detection of Methylation of Cervi-M Cervical Cancer
下载PDF
导出
摘要 目的探讨Cervi-M宫颈癌甲基化基因检测其诊断临床应用价值情况。方法选取于2017年1月—2018年1月在本院就诊的高危型HPV感染患者94例,进行Cervi-M宫颈癌甲基化基因检测及进行病理检测,收集患者相关资料,进行回顾性分析;依据不同的病理分级结果情况,进行分组;对比每组HPV检出阳性率与PAX1基因的甲基化检测阳性率。结果病理检出结果为正常宫颈组织HPV阳性检出率35.0%,PAX1基因甲基化检出率0.0%;低级别病变HPV阳性检出率78.3%,PAX1基因甲基化检出率13.0%;高级别病变HPV阳性检出率81.5%,PAX1基因甲基化检出率29.6%;宫颈癌HPV阳性检出率83.3%,PAX1基因甲基化检出率100.0%。宫颈癌PAX1基因甲基化检出率高于HPV阳性检出率。结论 Cervi-M宫颈癌甲基化基因检测,进一步提高了治疗的准确率,可应用于宫颈癌早期筛查与检测,更准确的辅助临床诊断和采取对应的干预治疗措施。 Objective To investigate the clinical value of genetic testing of methylation of Cervi-M cervical cancer.Methods A total of 94 patients with high-risk HPV infection who were admitted to our hospital from January 2017 to January 2018 were enrolled,genetic testing of methylation of Cervi-M cervical cancer and pathological examination were performed.Patient-related data was collected for retrospective review.Patients weredivided into groups according to different pathological grading results,the positive rate of HPV detection and the positive rate of methylation detection of PAX1 gene were compared in two groups.Results The pathological detection results showed that the positive rate of HPV of normal cervical tissues was 35.0%,the detection rate of methylation of PAX1 gene was 0.0%;the positive rate of HPV in low-grade lesions was 78.3%,and the detection rate of methylation of PAX1 gene was 13.0%.The positive rate of HPV in high-level lesions was 81.5%,the methylation rate of PAX1 gene was 29.6%,the positive rate of cervical cancer HPV was 83.3%,and the methylation rate of PAX1 gene was 100.0%.The detection rate of methylation of PAX1 gene in cervical cancer was significantly higher than that of HPV.Conclusion The genetic testing of methylation of Cervi-M cervical cancer gene can further improve the accuracy of treatment.It can be used for early screening,detection of cervical cancer,more accurate clinical diagnosis and corresponding intervention treatment.
作者 王静 龚培尧 梁慧 刘杰 WANG Jing;GONG Peiyao;LIANG Hui;LIU Jie(Department of Clinical Laboratory,Xuzhou Maternal and Child Health Hospital,Xuzhou Jiangsu 221009,China;Department of Pathology,Xuzhou Maternal and Child Health Hospital,Xuzhou Jiangsu 221009,China;Department of Cervical Services,Xuzhou Maternal and Child Health Hospital,Xuzhou Jiangsu 221009,China)
出处 《中国卫生标准管理》 2018年第22期104-106,共3页 China Health Standard Management
关键词 宫颈癌 基因检测 应用价值 DNA甲基化 诊断分析 新型分子筛查技术-Cervi-M cervical cancer genetic testing application value DNA methylation diagnostic analysis new molecular screening technology-Cervi-M
  • 相关文献

参考文献10

二级参考文献116

  • 1徐军,林晓,王红琳,王治洁,陆杲川,周红卫.p16和CDH1基因异常甲基化在宫颈组织中的表达及其意义[J].现代妇产科进展,2007,16(2):127-129. 被引量:2
  • 2徐军,王红琳,陆杲川,王治洁,林晓,周宏卫.子宫颈癌组织中抑癌基因DNA甲基化的检测[J].中华妇产科杂志,2007,42(6):394-397. 被引量:2
  • 3林晓,徐军,王红琳.RASSF1A和p16基因甲基化在子宫颈癌组织中的表达及意义[J].肿瘤,2007,27(9):727-729. 被引量:14
  • 4Parkin D M,Bray F,Ferlay J. Global cancer statistics,2002[J].CA Cancer J C lin,2005,(01):74-78.
  • 5Ahmedin J,Freddie B,Melissa M. Global cancer statistics,2011[J].{H}CA-A Cancer Journal for Clinicians,2011,(02):69-90.
  • 6Laird P W. Principles and challenges of genome-wide DNA methylation analysis[J].{H}Nature Reviews Genetics,2010,(03):191-203.
  • 7Bhutani N,Brady J J,Damian M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation[J].{H}NATURE,2010,(7284):1042-1047.
  • 8Tomita H,Hiratr A,Yamada Y. Suppressive effect of global DNA hypomethylation on gastric carcinogenesis[J].{H}CARCINOGENESIS,2010,(09):1627-1633.
  • 9Wolff E M,Byun H M,Han H F. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer[J].{H}PLoS Genetics,2010,(04):917-1000.
  • 10Sharma S,Kelly T K,Jones P A. Epigenetics in cancer[J].{H}CARCINOGENESIS,2010,(01):27-36.

共引文献289

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部